Mackay Shields LLC’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-14,300
| Closed | -$1.36M | – | 1039 |
|
|
2021
Q1 | $1.36M | Sell |
14,300
-9,751
| -41% | -$927K | 0.01% | 912 |
|
|
2020
Q4 | $1.49M | Buy |
24,051
+320
| +1% | +$19.9K | 0.01% | 961 |
|
|
2020
Q3 | $1.41M | Buy |
23,731
+2,565
| +12% | +$153K | 0.01% | 913 |
|
|
2020
Q2 | $1.48M | Sell |
21,166
-3,847
| -15% | -$268K | 0.01% | 894 |
|
|
2020
Q1 | $1.14M | Buy |
25,013
+3,206
| +15% | +$145K | 0.01% | 908 |
|
|
2019
Q4 | $1.42M | Sell |
21,807
-3,046
| -12% | -$198K | 0.01% | 986 |
|
|
2019
Q3 | $1.54M | Sell |
24,853
-962
| -4% | -$59.7K | 0.01% | 1008 |
|
|
2019
Q2 | $1.84M | Buy |
25,815
+15,202
| +143% | +$1.08M | 0.01% | 929 |
|
|
2019
Q1 | $832K | Sell |
10,613
-321
| -3% | -$25.2K | 0.01% | 1055 |
|
|
2018
Q4 | $926K | Sell |
10,934
-468
| -4% | -$39.6K | 0.01% | 964 |
|
|
2018
Q3 | $1.95M | Sell |
11,402
-160
| -1% | -$27.4K | 0.01% | 712 |
|
|
2018
Q2 | $1.5M | Sell |
11,562
-3,367
| -23% | -$435K | 0.01% | 852 |
|
|
2018
Q1 | $1.54M | Buy |
+14,929
| New | +$1.54M | 0.01% | 866 |
|